Search

Displaying results 5241 - 5250 of 10000 in total
  1. Target

    5-formyltetrahydrofolate cyclo-ligase

    go.drugbank.com/bio_entities/BE0001906
    TargetMycoplasma pneumoniae (strain ATCC 29342 / M129)

    Catalyzes the irreversible conversion of 5-formyltetrahydrofolate (5-FTHF) to yield 5,10-methenyltetrahydrofolate.

    Polypeptides: 5-formyltetrahydrofolate cyclo-ligaseFunction: 5-formyltetrahydrofolate cyclo-ligase activity
  2. Target

    Adenylate cyclase type 5

    go.drugbank.com/bio_entities/BE0003733
    TargetHumans

    Catalyzes the formation of the signaling molecule cAMP in response to G protein signaling (PubMed:15385642, PubMed:24700542, PubMed:26206488). Mediates signaling downstream of ADRB1 (PubMed:24700542). Regulates the increase of free cytos...

    Polypeptides: Adenylate cyclase type 5Synonyms: Adenylyl cyclase 5, ATP pyrophosphate-lyase 5
  3. Target

    Ribose-5-phosphate isomerase

    go.drugbank.com/bio_entities/BE0004438
    TargetHumans

    Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway

    Polypeptides: Ribose-5-phosphate isomerase
  4. Target

    Uridine 5'-monophosphate synthase

    go.drugbank.com/bio_entities/BE0004473
    TargetEnzymeHumans

    -5'-monophosphate decarboxylase (ODC), the terminal enzymatic reaction that decarboxylates OMP to uridine monophosphate (UMP) … Bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT), which converts orotate to orotidine-5'-monophosphate (OMP), and orotidine

    Polypeptides: Uridine 5'-monophosphate synthase
  5. Target

    5-hydroxytryptamine receptor 3C

    go.drugbank.com/bio_entities/BE0009584
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3CSynonyms: 5-HT3C, 5-HT3-C
  6. Target

    5-hydroxytryptamine 3 receptor

    go.drugbank.com/bio_entities/BE0009860
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons … Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3A, 5-hydroxytryptamine receptor 3BSynonyms: 5-HT-3, 5-HT3A
  7. Target

    5-hydroxytryptamine receptor 3

    go.drugbank.com/bio_entities/BE0010272
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons … Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3A, 5-hydroxytryptamine receptor 3BSynonyms: 5-HT-3, 5-HT3A
  8. Drug

    Etravirine

    go.drugbank.com/drugs/DB06414
    ApprovedInvestigational

    On March 26, 2012, approval was extended for use in treatment-experienced pediatric patients 6 to 18 years of age, weighing at least 16 kg. … Etraverine is used clinically for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

    Categories: Heterocyclic Compounds, 1-Ring, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase InhibitorProducts: INTELENCE®TABLETAS 200MG, INTELENCE TABLET 200 MG
  9. Drug

    Aprepitant

    go.drugbank.com/drugs/DB00673
    ApprovedInvestigational

    Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting … Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.

    Mixtures: EMEND® 80 MG/125 MG, EMEND® 80 MG/125 MGCategories: Neurokinin 1 Antagonists, Substance P/Neurokinin-1 Receptor Antagonist
  10. Drug

    Tetanus immune globulin, human

    go.drugbank.com/drugs/DB11604
    ApprovedInvestigational

    It contains antibodies against tetanus toxoid and is primarily used as prophylaxis against tetanus in wounded patients.

    Products: TETAGAM P 250 IU/1 ML IM KULLANIMA HAZIR ENJEKTÖRDE ENJEKSİYONLUK ÇÖZELTİ, TETANUS GAMMA KEDRION ® 250 UI/1 ML